Study links obesity to breast cancer According to two new studies, obesity increases the risk for breast cancer in post-menopausal Hispanic and African-American women.
More evidence poor cancer patients don't join clinical trials Low-income cancer patients are much less likely to participate in clinical trials than their more affluent peers, a U.S. study confirms.
Connecticut teen who fought chemotherapy treatment home from hospital A 17-year-old girl forced by the courts to undergo chemotherapy for her cancer has finished that treatment and was released Monday from a hospital where she had been confined since December.
Estrogen's role in breast cancer— and how to reduce your disease risk According to new government predictions, the number of women diagnosed with breast cancer will rise by as much as 50 percent by 2030.
New blood test for prostate cancer improves diagnostic accuracy A new blood test for prostate cancer is improving the accuracy of diagnoses and may even reduce the frequency of false positives and unnecessary biopsies
Roche breast cancer drug 'unprecedented' in extending lives A new breast cancer drug from Roche has shown "unprecedented" benefits in extending lives in a clinical trial and experts urged its widespread use for women with an aggressive form of the disease.
Dogs can detect prostate cancer in urine Highly-trained dogs are able to detect prostate cancer in urine with 98 percent accuracy, according to a study presented May 18 at the annual meeting of the American Urological Association in Orlando.
Teen has mastectomy after docs fail to spot breast cancer because she was ‘too young’ After two years of discomfort, a British teen was diagnosed with breast cancer— which doctors initially missed because she was “too young,” the U.K.’s Metro reported.
Tweaked approach to combining surgery, chemotherapy shows positive signs against ovarian cancer Cancer researchers have developed a new treatment strategy that holds promise for significantly extending the lives of women diagnosed with advanced ovarian cancer, one of the toughest to treat and most lethal malignancies.
New cancer drugs 'vastly overestimated,' says contrarian analyst A hot new class of drugs designed to help the body's own immune system fend off cancer by blocking a protein called PD-1 is going to be big— but not nearly as big as investors think, according to a new analysis.
